5,293 research outputs found

    On the existence of self-similar spherically symmetric wave maps coupled to gravity

    Get PDF
    We present a detailed analytical study of spherically symmetric self-similar solutions in the SU(2) sigma model coupled to gravity. Using a shooting argument we prove that there is a countable family of solutions which are analytic inside the past self-similarity horizon. In addition, we show that for sufficiently small values of the coupling constant these solutions possess a regular future self-similarity horizon and thus are examples of naked singularities. One of the solutions constructed here has been recently found as the critical solution at the threshold of black hole formation.Comment: 15 pages, LaTe

    On the equivalence of two deformation schemes in quantum field theory

    Get PDF
    Two recent deformation schemes for quantum field theories on the two-dimensional Minkowski space, making use of deformed field operators and Longo-Witten endomorphisms, respectively, are shown to be equivalent.Comment: 14 pages, no figure. The final version is available under Open Access. CC-B

    Warped Convolutions, Rieffel Deformations and the Construction of Quantum Field Theories

    Get PDF
    Warped convolutions of operators were recently introduced in the algebraic framework of quantum physics as a new constructive tool. It is shown here that these convolutions provide isometric representations of Rieffel's strict deformations of C*-dynamical systems with automorphic actions of R^n, whenever the latter are presented in a covariant representation. Moreover, the device can be used for the deformation of relativistic quantum field theories by adjusting the convolutions to the geometry of Minkowski space. The resulting deformed theories still comply with pertinent physical principles and their Tomita-Takesaki modular data coincide with those of the undeformed theory; but they are in general inequivalent to the undeformed theory and exhibit different physical interpretations.Comment: 34 page

    Delay-Exponent of Bilayer Anytime Code

    Full text link
    In this paper, we study the design and the delay-exponent of anytime codes over a three terminal relay network. We propose a bilayer anytime code based on anytime spatially coupled low-density parity-check (LDPC) codes and investigate the anytime characteristics through density evolution analysis. By using mathematical induction technique, we find analytical expressions of the delay-exponent for the proposed code. Through comparison, we show that the analytical delay-exponent has a close match with the delay-exponent obtained from numerical results.Comment: Accepted for presentation in ITW-2014. 5 Pages, 3 Figure

    Finite Length Analysis of LDPC Codes

    Full text link
    In this paper, we study the performance of finite-length LDPC codes in the waterfall region. We propose an algorithm to predict the error performance of finite-length LDPC codes over various binary memoryless channels. Through numerical results, we find that our technique gives better performance prediction compared to existing techniques.Comment: Submitted to WCNC 201

    Deformations of Fermionic Quantum Field Theories and Integrable Models

    Full text link
    Considering the model of a scalar massive Fermion, it is shown that by means of deformation techniques it is possible to obtain all integrable quantum field theoretic models on two-dimensional Minkowski space which have factorizing S-matrices corresponding to two-particle scattering functions S_2 satisfying S_2(0) = -1. Among these models there is for example the Sinh-Gordon model. Our analysis provides a complement to recent developments regarding deformations of quantum field theories. The deformed model is investigated also in higher dimensions. In particular, locality and covariance properties are analyzed.Comment: 20 page

    An operator expansion for integrable quantum field theories

    Full text link
    A large class of quantum field theories on 1+1 dimensional Minkowski space, namely, certain integrable models, has recently been constructed rigorously by Lechner. However, the construction is very abstract and the concrete form of local observables in these models remains largely unknown. Aiming for more insight into their structure, we establish a series expansion for observables, similar but not identical to the well-known form factor expansion. This expansion will be the basis for a characterization and explicit construction of local observables, to be discussed elsewhere. Here, we establish the expansion independent of the localization aspect, and analyze its behavior under space-time symmetries. We also clarify relations with deformation methods in quantum field theory, specifically, with the warped convolution in the sense of Buchholz and Summers.Comment: minor corrections and clarifications, as published in J. Phys A; 24 page

    Rebutting Obviousness in the Pharmaceutical Industry: Secondary Considerations of Analogs

    Get PDF
    Pharmaceutical companies depend on patent protection to recuperate the high costs of research and development. In regards to the patentability of structurally related compounds, the courts must decide whether a compound is obvious in view of its structurally similar prior art. In general, a compound is non-obvious over the structurally related prior art if the compound exhibits unexpected results. However, placing primary emphasis on a compound\u27s unexpected properties is out of step with the realities of drug development. For example, during drug development, chemists will modify a compound\u27s structure until they produce a compound that exhibits optimal pharmakinetic properties. This iterative process relies on the perseverance of scientists to pave the road to drug discovery-not unexpected results. This Note advocates for the elevation of the failure of others to make a drug that benefits society and the long-felt but unmet need for that treatment in the obviousness inquiry. These factors highlight the underappreciated realities of the drug discovery process, the immense effort that precedes a drug\u27s delivery to market, and the profound effect pharmaceuticals can have on disease treatment. In giving greater credence to the failure of others to develop a drug and the unmet need for that treatment, courts can resolve the current disconnect between the laboratory and patent law. By rewarding innovators that embark on a logical research plan that ends in the development of a beneficial drug, patent law will encourage companies to invest in drug development and produce drugs that benefit society

    Rebutting Obviousness in the Pharmaceutical Industry: Secondary Considerations of Analogs

    Get PDF
    Pharmaceutical companies depend on patent protection to recuperate the high costs of research and development. In regards to the patentability of structurally related compounds, the courts must decide whether a compound is obvious in view of its structurally similar prior art. In general, a compound is non-obvious over the structurally related prior art if the compound exhibits unexpected results. However, placing primary emphasis on a compound\u27s unexpected properties is out of step with the realities of drug development. For example, during drug development, chemists will modify a compound\u27s structure until they produce a compound that exhibits optimal pharmakinetic properties. This iterative process relies on the perseverance of scientists to pave the road to drug discovery-not unexpected results. This Note advocates for the elevation of the failure of others to make a drug that benefits society and the long-felt but unmet need for that treatment in the obviousness inquiry. These factors highlight the underappreciated realities of the drug discovery process, the immense effort that precedes a drug\u27s delivery to market, and the profound effect pharmaceuticals can have on disease treatment. In giving greater credence to the failure of others to develop a drug and the unmet need for that treatment, courts can resolve the current disconnect between the laboratory and patent law. By rewarding innovators that embark on a logical research plan that ends in the development of a beneficial drug, patent law will encourage companies to invest in drug development and produce drugs that benefit society
    • …
    corecore